Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Blackstone Completes Share Purchase Plan July 28, 2025 Comet share sale and debt repayment July 28, 2025 Agreement to Develop New Expandable Graphite Facility July 28, 2025